Executive Summary
Dr. Wu Skincare Co., Ltd. develops and sells skincare products in Taiwan and internationally. More Details
Rewards
Risk Analysis
Snowflake Analysis
Flawless balance sheet and undervalued.
Similar Companies
Share Price & News
How has Dr. Wu Skincare's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 6523 is not significantly more volatile than the rest of TW stocks over the past 3 months, typically moving +/- 6% a week.
Volatility Over Time: 6523's weekly volatility (6%) has been stable over the past year.
Market Performance
7 Day Return
5.4%
6523
3.2%
TW Personal Products
-1.7%
TW Market
1 Year Return
18.2%
6523
-5.8%
TW Personal Products
42.3%
TW Market
Return vs Industry: 6523 exceeded the TW Personal Products industry which returned -5.8% over the past year.
Return vs Market: 6523 underperformed the TW Market which returned 42.3% over the past year.
Shareholder returns
| 6523 | Industry | Market | |
|---|---|---|---|
| 7 Day | 5.4% | 3.2% | -1.7% |
| 30 Day | 3.1% | 3.1% | 1.3% |
| 90 Day | 1.1% | 2.2% | 2.0% |
| 1 Year | 30.4%18.2% | -4.0%-5.8% | 45.3%42.3% |
| 3 Year | 4.7%-22.6% | -10.3%-16.4% | 73.3%56.7% |
| 5 Year | -57.4%-69.7% | 26.5%10.9% | 131.1%93.5% |
Long-Term Price Volatility Vs. Market
How volatile is Dr. Wu Skincare's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 months ago | Simply Wall St
Would Shareholders Who Purchased Dr. Wu Skincare's (GTSM:6523) Stock Five Years Be Happy With The Share price Today?3 months ago | Simply Wall St
Only Three Days Left To Cash In On Dr. Wu Skincare's (GTSM:6523) DividendValuation
Is Dr. Wu Skincare undervalued compared to its fair value and its price relative to the market?
38.0%
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: 6523 (NT$76.5) is trading below our estimate of fair value (NT$123.32)
Significantly Below Fair Value: 6523 is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: 6523 is good value based on its PE Ratio (5x) compared to the TW Personal Products industry average (16.1x).
PE vs Market: 6523 is good value based on its PE Ratio (5x) compared to the TW market (18.7x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 6523's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 6523 is good value based on its PB Ratio (1.8x) compared to the TW Personal Products industry average (2x).
Future Growth
How is Dr. Wu Skincare forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
18.1%
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Dr. Wu Skincare has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Past Performance
How has Dr. Wu Skincare performed over the past 5 years?
9.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 6523 has a high level of non-cash earnings.
Growing Profit Margin: 6523's current net profit margins (84.9%) are higher than last year (20%).
Past Earnings Growth Analysis
Earnings Trend: 6523's earnings have grown by 9.2% per year over the past 5 years.
Accelerating Growth: 6523's earnings growth over the past year (270.7%) exceeds its 5-year average (9.2% per year).
Earnings vs Industry: 6523 earnings growth over the past year (270.7%) exceeded the Personal Products industry 4.7%.
Return on Equity
High ROE: 6523's Return on Equity (36.5%) is considered high.
Financial Health
How is Dr. Wu Skincare's financial position?
Financial Position Analysis
Short Term Liabilities: 6523's short term assets (NT$2.3B) exceed its short term liabilities (NT$479.3M).
Long Term Liabilities: 6523's short term assets (NT$2.3B) exceed its long term liabilities (NT$23.5M).
Debt to Equity History and Analysis
Debt Level: 6523 is debt free.
Reducing Debt: 6523 had no debt 5 years ago.
Debt Coverage: 6523 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 6523 has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Dividend
What is Dr. Wu Skincare current dividend yield, its reliability and sustainability?
5.23%
Current Dividend Yield
Dividend Yield vs Market
Notable Dividend: 6523's dividend (5.23%) is higher than the bottom 25% of dividend payers in the TW market (1.81%).
High Dividend: 6523's dividend (5.23%) is in the top 25% of dividend payers in the TW market (4.92%)
Stability and Growth of Payments
Stable Dividend: 6523 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: 6523's dividend payments have increased, but the company has only paid a dividend for 5 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (25.9%), 6523's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: Insufficient data to determine if a dividend will be paid in 3 years and that it will be covered by earnings.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
3.3yrs
Average management tenure
CEO
Eric Wu
no data
Tenure
Dr. Yi-Ju Wu, also known as Eric, is a Founder of Dr. Wu Skincare Co., Ltd and serves as its Chairman and has been its Director since February 27, 2003 and serves as its Chief Executive Officer.
Leadership Team
Experienced Management: 6523's management team is considered experienced (3.3 years average tenure).
Board Members
Experienced Board: 6523's board of directors are considered experienced (4.7 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
Dr. Wu Skincare Co., Ltd.'s company bio, employee growth, exchange listings and data sources
Key Information
- Name: Dr. Wu Skincare Co., Ltd.
- Ticker: 6523
- Exchange: TPEX
- Founded: 2003
- Industry: Personal Products
- Sector: Household
- Market Cap: NT$3.446b
- Shares outstanding: 45.05m
- Website: https://www.drwu.com
Location
- Dr. Wu Skincare Co., Ltd.
- No.70, Nanjing East Road
- 13th Floor
- Taipei
- 104
- Taiwan
Listings
Biography
Dr. Wu Skincare Co., Ltd. develops and sells skincare products in Taiwan and internationally. The company offers cleansers, masks, toners, serums, moisturizers, and sunscreen and eye care products, as well...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/07/25 09:18 |
| End of Day Share Price | 2021/07/23 00:00 |
| Earnings | 2021/03/31 |
| Annual Earnings | 2020/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.